MedPath

Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur

Recruiting
Conditions
Bone Metastases
Registration Number
NCT06918860
Lead Sponsor
Costantino Errani
Brief Summary

The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA or HHA or MegaTHA or Mega.

After pre-screening the databases of the respective sites, the investigators expect to find approximately a total of 600 patients. A review will be made from the medical records, radiological imaging, and histological data of partecipants.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Male and female adult patients surgically treated between 01/01/2000 and 31/12/2023 in Rizzoli Orthopaedic Institute and in Massachusetts General Hospital.
  • Age ≥18 y (at the time of surgery)
  • Patients with impending or pathological fracture due to bone metastases of the proximal femur (head/neck, intertrochanteric, subtrochanteric area).
  • Patients who underwent either IMN or THA or HHA or Mega or MegaTHA.
  • Patients with available clinical and imaging data.
Exclusion Criteria
  • Patients with pathological or impending fracture of proximal femur due to primary bone tumor.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysis of implant survivalthrough study completion, an average of 1 year

Assess the longevity associated with the different surgical treatments used for proximal femur bone metastases.

Analysis of complicationsAt baseline ( T0)

Assess the post-operative complications associated with the different surgical treatments used for proximal femur bone metastases.

Analysis of functional score1 year

Assess the functional score associated with the different surgical treatments used for proximal femur bone metastases.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Irccs Istituto Ortopedico Rizzoli

🇮🇹

Bologna, Emilia-Romagna, Italy

Irccs Istituto Ortopedico Rizzoli
🇮🇹Bologna, Emilia-Romagna, Italy
Costantino Errani, MD
Contact
0516366
costantino.errani@ior.it
Roberta Laranga, PhD
Contact
0616366
roberta.laranga@ior.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.